Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"

Ann Surg Oncol. 2021 Dec;28(Suppl 3):777-778. doi: 10.1245/s10434-021-10073-3. Epub 2021 May 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal
  • Breast Neoplasms* / surgery
  • Female
  • Humans
  • Ketorolac*
  • Mastectomy
  • Reoperation

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac